And so, but Danielle, by enabling this kind of broader health system reform approach, What do you see are the biggest opportunities in Femtech are in the innovation space by aligning with those bigger system reforms we're talking about?

So I think there's kind of two parts to that.

The first is the biggest benefit here is historically the underpinning data or the way we've modeled medicine information and the education and data that feeds into what our clinicians learn from is largely taken from college-age white Caucasian men.

So that's always been the clinical trials and that's largely just availability and how it's been done in the past.

So there is built-in bias even to how we address the actual information that we're learning from, applying symptom diagnosis.

So there is a real opportunity here as we digitize to actually collect meaningful data to fill that gap.

And that's probably the biggest benefit.

What about yourself, Danielle?